Page 2 - Therapeutics Program News Today

/PRNewswire/ -- Adela, Inc., focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test, has made appointments...

Researchers at Pfizer and BioNTech said they believe they can make an even better vaccine for shingles using promising messenger RNA technology perfected in their COVID-19 shots.

Yale research shows mice don’t gain weight on a high-fat diet when their astrocytes, a type of brain cell, are able to use fatty acids as fuel.

" " The Moderna and Pfizer mRNA COVID-19 vaccines have helped significantly reduce the number of cases of COVID-19 since they were first approved for emergency use. Dinendra Haria/SOPA Images/LightRocket via Getty Images For decades, researchers have dreamed about harnessing the power of genetic technology to prevent or treat a range of diseases. A synthetic version of a molecule in the human body known as messenger RNA (ribonucleic acid), or mRNA, held that promise. Just how to make it ...

Vaccine production company BioNTech said establishing manufacturing capabilities in Africa would likely take about four years.

According to the Mayo Clinic, some 290 million people are infected with malaria annually and at least 400,000 people die of the disease each year — predominantly young children, the elderly and the infirm — making it the world’s most pervasive parasitic disease. Symptoms involve ongoing cyclical “attacks — chills and shivering followed by fevers followed by chills followed by fevers. “Safe, effective, affordable vaccines could play a critical role in defeating malaria,” Dr Robert...

Share this article Share this article LEXINGTON, Mass., March 16, 2021 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the fourth quarter and year ended December 31, 2020. "2020 was a transformative year for Curis, as we made significant progress in our mission to develop the next generation of targeted cancer therapies that meaningfully improve and ex...